Clinical Trials Directory

Trials / Completed

CompletedNCT01242332

Perioperative Administration of Pregabalin in Patients Undergoing Arthroscopic Anterior Cruciate Ligament Reconstruction

Perioperative Administration of Pregabalin in Patients Undergoing Arthroscopic Anterior Cruciate Ligament Reconstruction: Does it Help to Relieve Postoperative Pain?

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Prince of Songkla University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To prove pregabalin's efficacy and safety in Thai patients scheduled for arthroscopic ACL reconstruction

Detailed description

Only eligible patients with willingness to join this study are included. Eligible patients are those aged 18-65 years of either sex, American Society of Anesthesiologists (ASA) physical status I \& II, and body mass index (BMI) between 16-35. The exclusion criteria are patients who are allergic to pregabalin, with impaired hepatic and renal functions, alcohol or substance abuse, chronic pain (except pain in the knee joint) or daily intake of analgesics, uncontrolled medical disease (hypertension and diabetes mellitus) and inability to operate patient-controlled analgesia (PCA) device. Data analysis * Student t-test for continuous data with normal distribution * Mann-Whitney U test for continuous data with non-normal distribution * Chi-square test for categorical data

Conditions

Interventions

TypeNameDescription
DRUGPregabalin75 mg po 2 hrs before surgery

Timeline

Start date
2009-08-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2010-11-17
Last updated
2010-11-17

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01242332. Inclusion in this directory is not an endorsement.